Back to search
FDAFDA · Food and drugs·Recall number D-0882-2017

Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA 90248, New Brunswick, NJ 08901, Product code L1229.

Published June 14, 2017 · Recall initiated: April 13, 2017

Summary

FDA records drug Class II recall D-0882-2017, published June 14, 2017 and initiated April 13, 2017. Recalling firm: Spectrum Laboratory Products, Inc.; Status: Terminated; Reported quantity: 1 container; Lot: Lot #: 2FD0376, Exp 02/21/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Spectrum Laboratory Products, Inc.
Distributor
Nationwide in the USA
Lot
Lot #: 2FD0376, Exp 02/21/21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA 90248, New Brunswick, NJ 08901, Product code L1229. recalled?

Yes. FDA published recall D-0882-2017 on June 14, 2017. Reported hazard: CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter